Article
RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes.
Haematologica - 1 Dec 2012
Greif Philipp A, Konstandin Nikola P, Metzeler Klaus H, Herold Tobias, Pasalic Zlatana, Ksienzyk Bianka, Dufour Annika, Schneider Friederike, Schneider Stephanie, Kakadia Purvi M, Braess Jan, Sauerland Maria Cristina, Berdel Wolfgang E, Büchner Thomas, Woermann Bernhard J, Hiddemann Wolfgang, Spiekermann Karsten, Bohlander Stefan K
Abstract excerpt
BACKGROUND: The RUNX1 (AML1) gene is a frequent mutational target in myelodysplastic syndromes and acute myeloid leukemia. Previous studies suggested that RUNX1 mutations may have pathological and prognostic implications. DESIGN AND METHODS: We screened 93 patients with cytogenetically normal acute myeloid leukemia for RUNX1 mutations by capillary sequencing of genomic DNA. Mutation status was then correlated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
